Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Environmental fate processes of antimicrobial peptides daptomycin, bacitracins, and polymyxins.

Davis CA, Janssen EM.

Environ Int. 2019 Nov 5;134:105271. doi: 10.1016/j.envint.2019.105271. [Epub ahead of print]

2.

Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancer.

Bridges JF, la Cruz M, Pavilack M, Flood E, Janssen EM, Chehab N, Fernandes AW.

Future Oncol. 2019 Dec;15(34):3895-3907. doi: 10.2217/fon-2019-0396. Epub 2019 Oct 17.

PMID:
31621403
3.

Shoot sodium exclusion in salt stressed barley (Hordeum vulgare L.) is determined by allele specific increased expression of HKT1;5.

van Bezouw RFHM, Janssen EM, Ashrafuzzaman M, Ghahramanzadeh R, Kilian B, Graner A, Visser RGF, van der Linden CG.

J Plant Physiol. 2019 Oct;241:153029. doi: 10.1016/j.jplph.2019.153029. Epub 2019 Aug 26.

4.

Examining Generalizability of Older Adults' Preferences for Discussing Cessation of Screening Colonoscopies in Older Adults with Low Health Literacy.

Schoenborn NL, Crossnohere NL, Janssen EM, Pollack CE, Boyd CM, Wolff AC, Xue QL, Massare J, Blinka M, Bridges JFP.

J Gen Intern Med. 2019 Nov;34(11):2512-2519. doi: 10.1007/s11606-019-05258-2. Epub 2019 Aug 26.

PMID:
31452029
5.

Gab3 is required for IL-2- and IL-15-induced NK cell expansion and limits trophoblast invasion during pregnancy.

Sliz A, Locker KCS, Lampe K, Godarova A, Plas DR, Janssen EM, Jones H, Herr AB, Hoebe K.

Sci Immunol. 2019 Aug 2;4(38). pii: eaav3866. doi: 10.1126/sciimmunol.aav3866.

PMID:
31375526
6.

How Do Older Adults Consider Age, Life Expectancy, Quality of Life, and Physician Recommendations When Making Cancer Screening Decisions? Results from a National Survey Using a Discrete Choice Experiment.

Janssen EM, Pollack CE, Boyd C, Bridges JFP, Xue QL, Wolff AC, Schoenborn NL.

Med Decis Making. 2019 Aug;39(6):621-631. doi: 10.1177/0272989X19853516. Epub 2019 Jun 21.

PMID:
31226903
7.

Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion.

Yang Y, Stang A, Schweickert PG, Lanman NA, Paul EN, Monia BP, Revenko AS, Palumbo JS, Mullins ES, Elzey BD, Janssen EM, Konieczny SF, Flick MJ.

Cancer Res. 2019 Jul 1;79(13):3417-3430. doi: 10.1158/0008-5472.CAN-18-3206. Epub 2019 May 2.

PMID:
31048498
8.

Exploring variation in parental worries about HPV vaccination: a latent-class analysis.

Gilkey MB, Mohan D, Janssen EM, McRee AL, Kornides ML, Bridges JFP.

Hum Vaccin Immunother. 2019;15(7-8):1745-1751. doi: 10.1080/21645515.2019.1574157. Epub 2019 May 7.

PMID:
30951396
9.

Cost of behavioral weight loss programs implemented in clinical practice: The POWER trial at Johns Hopkins.

Daumit GL, Janssen EM, Jerome GJ, Dalcin AT, Charleston J, Clark JM, Coughlin JW, Yeh HC, Miller ER, Durkin N, Louis TA, Frick KD, Wang NY, Appel LJ.

Transl Behav Med. 2019 Mar 11. pii: iby120. doi: 10.1093/tbm/iby120. [Epub ahead of print]

PMID:
30855082
10.

Demographic, health, and attitudinal factors predictive of cancer screening decisions in older adults.

Schoenborn NL, Xue QL, Pollack CE, Janssen EM, Bridges JFP, Wolff AC, Boyd CM.

Prev Med Rep. 2019 Jan 16;13:244-248. doi: 10.1016/j.pmedr.2019.01.007. eCollection 2019 Mar.

11.

Cyanobacterial peptides beyond microcystins - A review on co-occurrence, toxicity, and challenges for risk assessment.

Janssen EM.

Water Res. 2019 Mar 15;151:488-499. doi: 10.1016/j.watres.2018.12.048. Epub 2019 Jan 3. Review.

12.

AcroVoice: eliciting the patients' perspective on acromegaly disease activity.

Jackson Y, Flood E, Rhoten S, Janssen EM, Lundie M.

Pituitary. 2019 Feb;22(1):62-69. doi: 10.1007/s11102-018-00933-9.

13.

Loss of GTPase of immunity-associated protein 5 (Gimap5) promotes pathogenic CD4+ T-cell development and allergic airway disease.

Patterson AR, Bolcas P, Lampe K, Cantrell R, Ruff B, Lewkowich I, Hogan SP, Janssen EM, Bleesing J, Khurana Hershey GK, Hoebe K.

J Allergy Clin Immunol. 2019 Jan;143(1):245-257.e6. doi: 10.1016/j.jaci.2018.10.018. Epub 2018 Oct 25.

PMID:
30616774
14.

The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.

Agresta L, Hoebe KHN, Janssen EM.

Front Immunol. 2018 Nov 28;9:2809. doi: 10.3389/fimmu.2018.02809. eCollection 2018. Review.

15.

Older Adults' Preferences for Discussing Long-Term Life Expectancy: Results From a National Survey.

Schoenborn NL, Janssen EM, Boyd C, Bridges JFP, Wolff AC, Xue QL, Pollack CE.

Ann Fam Med. 2018 Nov;16(6):530-537. doi: 10.1370/afm.2309.

16.

Defective transcription elongation in a subset of cancers confers immunotherapy resistance.

Modur V, Singh N, Mohanty V, Chung E, Muhammad B, Choi K, Chen X, Chetal K, Ratner N, Salomonis N, Weirauch MT, Waltz S, Huang G, Privette-Vinnedge L, Park JS, Janssen EM, Komurov K.

Nat Commun. 2018 Oct 23;9(1):4410. doi: 10.1038/s41467-018-06810-0.

17.

Non-Singlet Oxygen Kinetic Solvent Isotope Effects in Aquatic Photochemistry.

Davis CA, McNeill K, Janssen EM.

Environ Sci Technol. 2018 Sep 4;52(17):9908-9916. doi: 10.1021/acs.est.8b01512. Epub 2018 Aug 16.

18.

Preferred Clinician Communication About Stopping Cancer Screening Among Older US Adults: Results From a National Survey.

Schoenborn NL, Janssen EM, Boyd CM, Bridges JFP, Wolff AC, Pollack CE.

JAMA Oncol. 2018 Aug 1;4(8):1126-1128. doi: 10.1001/jamaoncol.2018.2100. No abstract available.

19.

Proteomics Approach To Trace Site-Specific Damage in Aquatic Extracellular Enzymes During Photoinactivation.

Egli CM, Janssen EM.

Environ Sci Technol. 2018 Jul 17;52(14):7671-7679. doi: 10.1021/acs.est.7b06439. Epub 2018 Jul 5.

20.

Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy.

Hollin IL, Peay H, Fischer R, Janssen EM, Bridges JFP.

Qual Life Res. 2018 Sep;27(9):2261-2273. doi: 10.1007/s11136-018-1891-7. Epub 2018 May 26.

PMID:
29804169
21.

Identifying and prioritizing concerns associated with prosthetic devices for use in a benefit-risk assessment: a mixed-methods approach.

Janssen EM, Benz HL, Tsai JH, Bridges JF.

Expert Rev Med Devices. 2018 May;15(5):385-398. doi: 10.1080/17434440.2018.1470505. Epub 2018 May 8.

PMID:
29707973
22.

Project Transform: engaging patient advocates to share their perspectives on improving research, treatment and policy.

Bridges JFP, Janssen EM, Ferris A, Dy SM.

Curr Med Res Opin. 2018 Oct;34(10):1755-1762. doi: 10.1080/03007995.2018.1440199. Epub 2018 Mar 9.

PMID:
29429378
23.

Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.

Janssen EM, Hauber AB, Bridges JFP.

Value Health. 2018 Jan;21(1):59-68. doi: 10.1016/j.jval.2017.07.001. Epub 2017 Aug 7.

24.

Live, Learn, Pass It on: A Patient Advocacy Engagement Project on the Lived Experience of Lung Cancer Survivors.

Dy SM, Janssen EM, Ferris A, Bridges JF.

J Patient Exp. 2017 Dec;4(4):162-168. doi: 10.1177/2374373517714451. Epub 2017 Jun 16.

25.

STING, DCs and the link between innate and adaptive tumor immunity.

Vatner RE, Janssen EM.

Mol Immunol. 2019 Jun;110:13-23. doi: 10.1016/j.molimm.2017.12.001. Epub 2017 Dec 20. Review.

26.

Magnitude and Mechanism of Siderophore-Mediated Competition at Low Iron Solubility in the Pseudomonas aeruginosa Pyochelin System.

Schiessl KT, Janssen EM, Kraemer SM, McNeill K, Ackermann M.

Front Microbiol. 2017 Oct 10;8:1964. doi: 10.3389/fmicb.2017.01964. eCollection 2017.

27.

Education and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment.

Janssen EM, Longo DR, Bardsley JK, Bridges JF.

Patient Prefer Adherence. 2017 Oct 6;11:1729-1736. doi: 10.2147/PPA.S139471. eCollection 2017.

28.

Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability?

Janssen EM, Marshall DA, Hauber AB, Bridges JFP.

Expert Rev Pharmacoecon Outcomes Res. 2017 Dec;17(6):531-542. doi: 10.1080/14737167.2017.1389648. Epub 2017 Oct 23. Review.

PMID:
29058478
29.

Art and Science of Instrument Development for Stated-Preference Methods.

Janssen EM, Bridges JFP.

Patient. 2017 Aug;10(4):377-379. doi: 10.1007/s40271-017-0261-9. No abstract available.

PMID:
28616767
30.

A holistic approach to food safety risks: Food fraud as an example.

Marvin HJP, Bouzembrak Y, Janssen EM, van der Fels-Klerx HJ, van Asselt ED, Kleter GA.

Food Res Int. 2016 Nov;89(Pt 1):463-470. doi: 10.1016/j.foodres.2016.08.028. Epub 2016 Aug 25.

PMID:
28460939
31.

Environmental photochemistry of fenamate NSAIDs and their radical intermediates.

Davis CA, Erickson PR, McNeill K, Janssen EML.

Environ Sci Process Impacts. 2017 May 24;19(5):656-665. doi: 10.1039/c7em00079k.

PMID:
28401228
32.

A cost analysis of implementing a behavioral weight loss intervention in community mental health settings: Results from the ACHIEVE trial.

Janssen EM, Jerome GJ, Dalcin AT, Gennusa JV 3rd, Goldsholl S, Frick KD, Wang NY, Appel LJ, Daumit GL.

Obesity (Silver Spring). 2017 Jun;25(6):1006-1013. doi: 10.1002/oby.21836. Epub 2017 Apr 11.

33.

Type I interferons regulate susceptibility to inflammation-induced preterm birth.

Cappelletti M, Presicce P, Lawson MJ, Chaturvedi V, Stankiewicz TE, Vanoni S, Harley IT, McAlees JW, Giles DA, Moreno-Fernandez ME, Rueda CM, Senthamaraikannan P, Sun X, Karns R, Hoebe K, Janssen EM, Karp CL, Hildeman DA, Hogan SP, Kallapur SG, Chougnet CA, Way SS, Divanovic S.

JCI Insight. 2017 Mar 9;2(5):e91288. doi: 10.1172/jci.insight.91288.

34.

Application of Bayesian networks for hazard ranking of nanomaterials to support human health risk assessment.

Marvin HJ, Bouzembrak Y, Janssen EM, van der Zande M, Murphy F, Sheehan B, Mullins M, Bouwmeester H.

Nanotoxicology. 2017 Feb;11(1):123-133. doi: 10.1080/17435390.2016.1278481.

PMID:
28044458
35.

Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis.

dosReis S, Park A, Ng X, Frosch E, Reeves G, Cunningham C, Janssen EM, Bridges JFP.

J Child Adolesc Psychopharmacol. 2017 Apr;27(3):234-242. doi: 10.1089/cap.2016.0157. Epub 2016 Dec 19.

36.

Big data in food safety: An overview.

Marvin HJ, Janssen EM, Bouzembrak Y, Hendriksen PJ, Staats M.

Crit Rev Food Sci Nutr. 2017 Jul 24;57(11):2286-2295. doi: 10.1080/10408398.2016.1257481. Review.

PMID:
27819478
37.

Using Best-Worst Scaling to Investigate Preferences in Health Care.

Cheung KL, Wijnen BF, Hollin IL, Janssen EM, Bridges JF, Evers SM, Hiligsmann M.

Pharmacoeconomics. 2016 Dec;34(12):1195-1209. Review.

38.

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity.

Tel J, Benitez-Ribas D, Janssen EM, Smits EL, Jacobs JF.

Mediators Inflamm. 2016;2016:5789725. doi: 10.1155/2016/5789725. Epub 2016 May 31. No abstract available.

39.

Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools.

Klarquist J, Zhou Z, Shen N, Janssen EM.

Mediators Inflamm. 2016;2016:5045248. doi: 10.1155/2016/5045248. Epub 2016 Mar 30. Review.

40.

A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes.

Janssen EM, Segal JB, Bridges JF.

Patient. 2016 Oct;9(5):465-79. doi: 10.1007/s40271-016-0170-3.

PMID:
27120338
41.

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice.

Klarquist J, Janssen EM.

J Vis Exp. 2015 Nov 1;(105):e53319. doi: 10.3791/53319.

42.

Environmental Photochemistry of Amino Acids, Peptides and Proteins.

Lundeen RA, Janssen EM, Chu C, Mcneill K.

Chimia (Aarau). 2014 Nov;68(11):812-7. doi: 10.2533/chimia.2014.812.

PMID:
26508490
43.

Ablation of CD8α(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice.

Legein B, Janssen EM, Theelen TL, Gijbels MJ, Walraven J, Klarquist JS, Hennies CM, Wouters K, Seijkens TT, Wijnands E, Sluimer JC, Lutgens E, Zenke M, Hildner K, Biessen EA, Temmerman L.

Sci Rep. 2015 Oct 21;5:15414. doi: 10.1038/srep15414.

44.

Loss of Phagocytic and Antigen Cross-Presenting Capacity in Aging Dendritic Cells Is Associated with Mitochondrial Dysfunction.

Chougnet CA, Thacker RI, Shehata HM, Hennies CM, Lehn MA, Lages CS, Janssen EM.

J Immunol. 2015 Sep 15;195(6):2624-32. doi: 10.4049/jimmunol.1501006. Epub 2015 Aug 5.

45.

Quantitating MHC class II trafficking in primary dendritic cells using imaging flow cytometry.

Hennies CM, Lehn MA, Janssen EM.

J Immunol Methods. 2015 Aug;423:18-28. doi: 10.1016/j.jim.2015.04.023. Epub 2015 May 9.

46.

Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness.

Janssen EM, McGinty EE, Azrin ST, Juliano-Bult D, Daumit GL.

Gen Hosp Psychiatry. 2015 May-Jun;37(3):199-222. doi: 10.1016/j.genhosppsych.2015.03.004. Epub 2015 Mar 14. Review.

47.

Aquatic photochemical kinetics of benzotriazole and structurally related compounds.

Janssen EM, Marron E, McNeill K.

Environ Sci Process Impacts. 2015 May;17(5):939-46. doi: 10.1039/c5em00045a. Epub 2015 Mar 27.

PMID:
25816109
48.

Environmental photoinactivation of extracellular phosphatases and the effects of dissolved organic matter.

Janssen EM, McNeill K.

Environ Sci Technol. 2015 Jan 20;49(2):889-96.

PMID:
25495644
49.

STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells.

Klarquist J, Hennies CM, Lehn MA, Reboulet RA, Feau S, Janssen EM.

J Immunol. 2014 Dec 15;193(12):6124-34. doi: 10.4049/jimmunol.1401869. Epub 2014 Nov 10.

50.

DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells.

Zhang X, Ulm A, Somineni HK, Oh S, Weirauch MT, Zhang HX, Chen X, Lehn MA, Janssen EM, Ji H.

Epigenetics Chromatin. 2014 Aug 20;7:21. doi: 10.1186/1756-8935-7-21. eCollection 2014.

Supplemental Content

Loading ...
Support Center